Cumberland Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.36M | Buy |
+3,500
| New | +$1.36M | 0.09% | 122 |
|
2024
Q4 | – | Sell |
-19,396
| Closed | -$10.1M | – | 178 |
|
2024
Q3 | $10.1M | Buy |
19,396
+155
| +0.8% | +$80.6K | 0.7% | 34 |
|
2024
Q2 | $10.4M | Buy |
19,241
+634
| +3% | +$344K | 0.76% | 33 |
|
2024
Q1 | $9.65M | Sell |
18,607
-10,867
| -37% | -$5.63M | 0.7% | 33 |
|
2023
Q4 | $13M | Sell |
29,474
-406
| -1% | -$179K | 1.19% | 24 |
|
2023
Q3 | $13M | Sell |
29,880
-189
| -0.6% | -$82.3K | 1.25% | 24 |
|
2023
Q2 | $13.4M | Sell |
30,069
-217
| -0.7% | -$96.4K | 1.23% | 24 |
|
2023
Q1 | $13.9M | Sell |
30,286
-5,320
| -15% | -$2.45M | 1.37% | 25 |
|
2022
Q4 | $18.3M | Buy |
35,606
+15,154
| +74% | +$7.77M | 1.92% | 19 |
|
2022
Q3 | $9.29M | Buy |
20,452
+370
| +2% | +$168K | 0.99% | 31 |
|
2022
Q2 | $9.69M | Buy |
20,082
+8,232
| +69% | +$3.97M | 0.92% | 31 |
|
2022
Q1 | $5.82M | Sell |
11,850
-366
| -3% | -$180K | 0.44% | 53 |
|
2021
Q4 | $5.66M | Sell |
12,216
-1
| -0% | -$464 | 0.4% | 63 |
|
2021
Q3 | $4.55M | Buy |
12,217
+422
| +4% | +$157K | 0.37% | 72 |
|
2021
Q2 | $4.5M | Sell |
11,795
-966
| -8% | -$369K | 0.35% | 74 |
|
2021
Q1 | $4.58M | Buy |
12,761
+933
| +8% | +$335K | 0.38% | 70 |
|
2020
Q4 | $3.8M | Buy |
11,828
+1,363
| +13% | +$438K | 0.34% | 72 |
|
2020
Q3 | $2.81M | Buy |
10,465
+1,906
| +22% | +$512K | 0.29% | 74 |
|
2020
Q2 | $2.25M | Buy |
8,559
+5,709
| +200% | +$1.5M | 0.23% | 82 |
|
2020
Q1 | $647K | Sell |
2,850
-1,175
| -29% | -$267K | 0.08% | 118 |
|
2019
Q4 | $1.22M | Buy |
4,025
+775
| +24% | +$234K | 0.11% | 106 |
|
2019
Q3 | $780K | Buy |
3,250
+1,500
| +86% | +$360K | 0.08% | 112 |
|
2019
Q2 | $494K | Buy |
+1,750
| New | +$494K | 0.05% | 138 |
|
2019
Q1 | – | Sell |
-4,700
| Closed | -$1.23M | – | 168 |
|
2018
Q4 | $1.23M | Buy |
+4,700
| New | +$1.23M | 0.14% | 92 |
|